In a report released on January 27, Jessica Fye from J.P. Morgan maintained a Buy rating on Intra-Cellular Therapies (ITCI – Research Report), ...

J.P. Morgan analyst Michael Mueller maintained a Buy rating on Prologis (PLD – Research Report) on January 24 and set a price target of ...

The move is the latest recruiting win for RBC Wealth Management as it continues to lure top talent away from big banks and ...

Tech stocks suffered on "worries that Beijing is becoming increasingly competitive in the high-stakes artificial intelligence ...

Venture Global, Inc. ("Venture Global") announced today the pricing of its initial public offering of 70,000,000 shares of its Class A common stock, par value $0.01 ("Class A common stock") at a ...

On Thursday, RBC Capital Markets adjusted its outlook on shares ... With a market capitalization of $709.92 billion and a P/E ratio of 12.93, JPM has maintained dividend payments for 55 ...

Issuance for next week falls to an estimated $5.151 billion, with $3.959 billion of negotiated deals and $1.193 billion of ...

While Biogen has made an opportunistic bid for partner Sage, its top executive seemed to play down the urgency for his ...